Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Lovat

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Cell Death and Differentiation|December 16, 2023
Role of Fra-2 in cancerGian Luca Rampioni Vinciguerra, Marina Capece, Giorgia Scafetta, et al.
Molecular and Cellular Biology|July 15, 2009
The tumor suppressor functions of p27(kip1) include control of the mesenchymal/amoeboid transitionStefania Berton, Barbara Belletti, Katarina Wolf, et al.
Molecular Cancer Therapeutics|May 17, 2008
p27Kip1 expression inhibits glioblastoma growth, invasion, and tumor-induced neoangiogenesisMonica Schiappacassi, Francesca Lovat, Vincenzo Canzonieri, et al.
Oncotarget|January 23, 2014
LZTS1 downregulation confers paclitaxel resistance and is associated with worse prognosis in breast cancerFrancesca Lovat, Hideshi Ishii, Monica Schiappacassi, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2021
Loss of expression of both miR-15/16 loci in CML transition to blast crisisFrancesca Lovat, Pierluigi Gasparini, Giovanni Nigita, et al.
Oncogene|March 31, 2023
A-to-I edited miR-411-5p targets MET and promotes TKI response in NSCLC-resistant cellsGiulia Romano, Patricia Le, Giovanni Nigita, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 2, 2015
miR-15b/16-2 deletion promotes B-cell malignanciesFrancesca Lovat, Matteo Fassan, Pierluigi Gasparini, et al.
Oncotarget|March 18, 2014
microRNA expression profiling identifies a four microRNA signature as a novel diagnostic and prognostic biomarker in triple negative breast cancersPierluigi Gasparini, Luciano Cascione, Matteo Fassan, et al.
Molecular Biology of the Cell|February 29, 2008
Stathmin activity influences sarcoma cell shape, motility, and metastatic potentialBarbara Belletti, Milena S Nicoloso, Monica Schiappacassi, et al.
Journal of Hypertension|July 23, 2013
Angiotensin-converting-enzyme inhibition counteracts angiotensin II-mediated endothelial cell dysfunction by modulating the p38/SirT1 axisFrancesco Marampon, Giovanni L Gravina, Luca Scarsella, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Cell Death and Differentiation|December 16, 2023
Role of Fra-2 in cancerGian Luca Rampioni Vinciguerra, Marina Capece, Giorgia Scafetta, et al.
Molecular and Cellular Biology|July 15, 2009
The tumor suppressor functions of p27(kip1) include control of the mesenchymal/amoeboid transitionStefania Berton, Barbara Belletti, Katarina Wolf, et al.
Molecular Cancer Therapeutics|May 17, 2008
p27Kip1 expression inhibits glioblastoma growth, invasion, and tumor-induced neoangiogenesisMonica Schiappacassi, Francesca Lovat, Vincenzo Canzonieri, et al.
Oncotarget|January 23, 2014
LZTS1 downregulation confers paclitaxel resistance and is associated with worse prognosis in breast cancerFrancesca Lovat, Hideshi Ishii, Monica Schiappacassi, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2021
Loss of expression of both miR-15/16 loci in CML transition to blast crisisFrancesca Lovat, Pierluigi Gasparini, Giovanni Nigita, et al.
Oncogene|March 31, 2023
A-to-I edited miR-411-5p targets MET and promotes TKI response in NSCLC-resistant cellsGiulia Romano, Patricia Le, Giovanni Nigita, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 2, 2015
miR-15b/16-2 deletion promotes B-cell malignanciesFrancesca Lovat, Matteo Fassan, Pierluigi Gasparini, et al.
Oncotarget|March 18, 2014
microRNA expression profiling identifies a four microRNA signature as a novel diagnostic and prognostic biomarker in triple negative breast cancersPierluigi Gasparini, Luciano Cascione, Matteo Fassan, et al.
Molecular Biology of the Cell|February 29, 2008
Stathmin activity influences sarcoma cell shape, motility, and metastatic potentialBarbara Belletti, Milena S Nicoloso, Monica Schiappacassi, et al.
Journal of Hypertension|July 23, 2013
Angiotensin-converting-enzyme inhibition counteracts angiotensin II-mediated endothelial cell dysfunction by modulating the p38/SirT1 axisFrancesco Marampon, Giovanni L Gravina, Luca Scarsella, et al.
Pageof 6